ENT Devices: Global Market Growth, Trends and Forecast Report, 2019 to 2024 - ResearchAndMarkets.com - Yahoo Finance

-

DUBLIN--(BUSINESS WIRE)--

The "ENT Devices Market - Growth, Trends, and Forecast (2019 - 2024)" report has been added to ResearchAndMarkets.com's offering.

The major factors for the growth of the ENT devices market include the increasing prevalence of ear, nose, and throat related disorders, rising adoption of minimally invasive ENT procedures, and technological advancements. Owing to the rising prevalence and new cases of ear, nose, and throat related disorders, the US ENT devices market is expected to witness a high CAGR over the forecast period.

Key Market Trends

Hearing Aids Expected to Account for the Fastest Growth Rate during the Forecast Period

As per the estimates of the Center for Hearing and Communication, 48 million Americans suffer significant hearing loss and one out of three people over the age of 65 have some degree of hearing loss. Hearing loss can occur at birth or can develop at any age. There are different types of hearing aids available in the market, and some of them include Behind the Ear (BTE), Receiver in the Ear (RITE), In the Ear (ITE), Canal Hearing Aids (CHA), and other hearing aid devices.

Furthermore, in the United States, the Individuals with Disabilities Education Act (IDEA) ensures that students with hearing loss receive proper education and accommodations, if necessary. Similarly, one of the organizations, the Hearing Loss Association of America (HLAA), offers training courses and online learning, holds monthly webinars, and advocates for the rights of people with hearing loss. Thus, the rising prevalence of hearing loss and increasing awareness among people is driving the segment and is set to witness a high CAGR over the forecast period.

North America Accounted for the Largest Share in the Global Market

North America is found to hold a major share for the ENT devices market and is expected to show a similar trend over the forecast period, without significant fluctuations. Most of the market players are based in North America and there is awareness about the advantages of using ENT devices solutions.

According to the estimates of the Hearing Health Foundation, there are 600,000-750,000 cases of Ménière’s disease in the United States, with 45,000 to 60,000 new cases diagnosed annually. Favorable reimbursement policies, better healthcare infrastructure, high cases of chronic sinusitis, and other ENT disorders are the reasons for the high market share of the United States.

Competitive Landscape

The market studied is consolidated owing to the presence of a few major players in the market. The market players are focusing on R&D to develop the technologically advanced products in order to bring innovative products in the market. The barriers for the new entrants are high in this industry and hence only a few major market players hold the maximum market share.

Key Topics Covered

1 INTRODUCTION

1.1 Study Deliverables

1.2 Study Assumptions

1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

4.1 Market Overview

4.2 Market Drivers

4.2.1 Increasing Prevalence of Ear, Nose, and Throat Related Disorders

4.2.2 Rising Adoption of Minimally Invasive ENT Procedures

4.2.3 Technological Advancements

4.3 Market Restraints

4.3.1 High Procedure and Instruments Cost

4.3.2 Social Stigma

4.4 Porter's Five Forces Analysis

5 MARKET SEGMENTATION

5.1 By Product

5.1.1 Diagnostic Devices

5.1.1.1 Endoscopes

5.1.1.1.1 Rigid Endoscopes

5.1.1.1.1.1 Otoscopes

5.1.1.1.1.2 Sinuscopes

5.1.1.1.2 Flexible Endoscopes

5.1.1.1.2.1 Laryngoscopes

5.1.1.1.2.2 Pharyngoscopes

5.1.1.1.2.3 Other Flexible Endoscopes

5.1.2 Surgical Devices

5.1.2.1 Powered Surgical Instruments

5.1.2.2 Radiofrequency (RF) Handpieces

5.1.2.3 Handheld Instruments

5.1.2.4 Balloon Sinus Dilation Devices

5.1.2.5 Other Surgical Devices

5.1.3 Hearing Aids

5.1.4 Image-guided Surgery Systems

5.1.5 Other Products

5.2 By End User

5.2.1 Hospitals

5.2.2 ENT Clinics

5.2.3 Other End Users

5.3 Geography

5.3.1 North America

5.3.2 Europe

5.3.3 Asia-Pacific

5.3.4 Middle East & Africa

5.3.5 South America

6 COMPETITIVE LANDSCAPE

6.1 Company Profiles

6.1.1 American Hearing Systems Inc.

6.1.2 Atos Medical

6.1.3 Cochlear Ltd.

6.1.4 InHealth Technologies

6.1.5 Medtronic PLC

6.1.6 Olympus Corporation

6.1.7 Siemens Healthcare GmbH

6.1.8 Starkey Laboratories Inc.

6.1.9 Stryker Corporation

6.1.10 Welch Allyn

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

For more information about this report visit https://www.researchandmarkets.com/r/t0ymuo

View source version on businesswire.com: https://www.businesswire.com/news/home/20190430005674/en/



https://yhoo.it/2UQyFAP

Comments

Post a Comment

Popular posts from this blog

Well-liked Medicare plan vs. higher-ranked providers - ChicagoNow

-
Image
Medicare Open Enrollment ends December 7. The easy choice is to stay with all-in-one Medicare Advantage instead of switching to Traditional Medicare plus a supplement and drug plan. The hard one is whether to switch between Medicare Advantage plans, from a well-liked one to one accepted at a so-called top-10 hospital. Humana Gold Plus, a Medicare Advantage HMO, has served me well for five years. Hearing aids cost me only $10 after its $2,000 allowance. Routine doctor and dentist appointments and my medication cost nothing. But Humana Gold Plus is not accepted by Northwestern Memorial Hospital, the nearby hospital that US News & World Report ranks as the tenth best in the country, or by Northwestern Medicine physicians. My primary care physician is in an Advocate Medical Group. If I were hospitalized, it would be at Advocate Illinois Masonic Medical Center. If I had a serious illness, I’d see specialists in Advocate’s network. Illinois Masonic is not a second-rate hospital, and
Read more

Minnesota veterans blame 3M's 'defective' ear plugs for hearing damage - KSTP

-
Image
3M did not admit any wrongdoing as part of that settlement. Read 3M's full statement on the ear plugs here. "We deny this product was defectively designed," a company spokesperson said in a statement to 5 INVESTIGATES, adding they will "defend against the allegations in these lawsuits." More than 630 lawsuits have been filed and will be heard in a federal court in Florida. An attorney involved with the multi-district litigation says roughly 30 have been filed by veterans who live in Minnesota. Constant ringing Sarah Kay Carlson, an Army veteran from St. Paul, filed her lawsuit in April, claiming 3M exposed her and thousands of other Marines and soldiers to "extremely dangerous and disabling noise." 3M Earplug Complaint (Sarah Kay Carlson) Ramsey County (Filed) (PDF) 3M Earplug Complaint (Sarah Kay Carlson) Ramsey County (Filed) (Text) Carlson, who was deployed as part of Operation Iraqi Freedom in the late 2000s, provided security to convoys t
Read more

Sickle Cell Disease (SCD): Practice Essentials, Background, Genetics

-
Image
hemophilia c factor 11 :: Article Creator Regeneron Reports Fourth Quarter And Full Year 2023 Financial And Operating Results Fourth quarter 2023 revenues increased 1% to $3.43 billion versus fourth quarter 2022; excluding RonapreveTM(a)(b), revenuesincreased 14% Full year 2023 revenues increased 8% to $13.12 billion versus full year 2022;excluding Ronapreve(a), revenuesincreased 12% Fourth quarter 2023 Dupixent®global net sales(recorded by Sanofi) increased 31% to $3.22 billion versus fourth quarter 2022; full year 2023 Dupixent global net sales increased 33% to $11.59 billion versus 2022 Fourth quarter 2023 U.S. Net sales for EYLEA®HD and EYLEA®were $1.46 billion, including $123 million from EYLEA HD; full year 2023 U.S. Net sales for EYLEA HD and EYLEA were $5.89 billion, including $166 million from EYLEA HD following its August 2023 FDA approval Fourth quarter 2023 Libtayo®global n
Read more